Becton Dickinson and Co
Change company Symbol lookup
Select an option...
BDX Becton Dickinson and Co
MSFT Microsoft Corp
ACC American Campus Communities Inc
PNFP Pinnacle Financial Partners Inc
SYF Synchrony Financial
TRV Travelers Companies Inc
IBM International Business Machines Corp
T AT&T Inc
MRK Merck & Co Inc
PFE Pfizer Inc
Go

Health Care : Health Care Equipment & Supplies | Large Cap Value
Company profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Closing Price
$256.44
Day's Change
-2.52 (-0.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
260.60
Day's Low
256.18
Volume
(Above Average)
Volume:
1,495,754

10-day average volume:
1,295,822
1,495,754

Display:

Providers:

UpdateCancel
6 providers
Yesterday's News, April 20, 2021
BD Announces the Voluntary Recall of Specified Lots of ChloraPrep(TM) Hi-Lite Orange(TM) 26 mL Applicator in the United States and U.S. Territories Due to Defective Applicator

BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep(TM) Hi-Lite Orange(TM) 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol...(PR Newswire)

BD Commits $1M To Fight Maternal And Neonatal Tetanus

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $1 million commitment over five years to UNICEF USA in support of UNICEF's work to uphold the rights of all children and help every child...(PR Newswire)

April 15, 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement

Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp...(PR Newswire)

April 14, 2021
BD Announces 510(k) Clearance of Pristine(TM) Long-Term Hemodialysis Catheter

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Pristine(TM) Long-Term Hemodialysis Catheter, a...(PR Newswire)

April 13, 2021
BD MAX(TM) Molecular Multi-Drug Resistant Tuberculosis Test To Be Included In WHO Updated Consolidated Guidelines On Tuberculosis

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX(TM) Molecular Multi-Drug Resistant Tuberculosis (MDR-TB) Assay was included in the moderate complexity automated NAAT class...(PR Newswire)

April 05, 2021
BD To Announce Financial Results For Its Second Quarter Of Fiscal 2021

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the second quarter of fiscal year 2021 on Thursday, May 6, 2021. BD will issue a press release detailing the quarter's results, along with...(PR Newswire)

April 01, 2021
BD to Invest $65 Million for Key Supply Chain Infrastructure in Tucson, Arizona to Increase Resiliency of U.S. Medical Device Supply

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company's supply chain...(PR Newswire)

BD Receives Emergency Use Authorization for Asymptomatic Screening for SARS-CoV-2 through Serial Rapid Antigen Testing

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its rapid antigen test to be used for...(PR Newswire)

March 30, 2021
BD Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a new, rapid antigen test that can detect...(PR Newswire)

March 09, 2021
BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion...(PR Newswire)

BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion...(PR Newswire)

March 04, 2021
Pharmaceutical Packaging Market Worth USD 153.93 Billion by 2027; Know the COVID-19 Impact Analysis on Pharmaceutical Packaging Industry Worldwide | Fortune Business Insights(TM)

The global pharmaceutical packaging industry is expected to reach USD 153.93 billion by 2027, exhibit a CAGR of 6.4% during the forecast period. The growing adoption of novel and generic drugs in developing countries will have...(Globe Newswire)

BD Acquires GSL Solutions, Inc., Broadening Medication Management Offerings for Retail, Outpatient Pharmacy Settings

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired GSL Solutions, Inc. ("GSL"), a privately-held company that develops smart medication devices for the storage and tracking of...(PR Newswire)

February 22, 2021
BD Announces Collaboration for At-Home Rapid Test for COVID-19

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Scanwell Health, a leader in smartphone-enabled at-home medical tests, today announced a collaboration to create an at-home rapid test for SARS-CoV-2...(PR Newswire)

February 12, 2021
BD to Present at Upcoming Investor Conferences

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences: -- The Leerink Virtual 10th Annual Global Healthcare Conference...(PR Newswire)

BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new molecular diagnostic test for both...(PR Newswire)

February 04, 2021
BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $5.315 billion for the first fiscal quarter ended December 31, 2020. This represents an increase of 25.8% over the...(PR Newswire)

February 02, 2021
First-of-its-Kind Randomized Clinical Trial Published in "The Lancet Infectious Diseases" Outlines Potential New Standard-Setting Best Practices for Peripheral IV Catheters

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that new clinical data have found robust evidence that using a vascular care solution can help improve outcomes for patients requiring...(PR Newswire)

January 26, 2021
Update in Lawsuit for Investors in shares of Becton, Dickinson and Company (NYSE: BDX) announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NYSE: BDX shares. Investors, who purchased NYSE: BDX shares in November 2019 or earlier and continue to hold any of those NYSE: BDX shares, have certain...(Globe Newswire)

BD Names CEO Tom Polen as Chairman of the Board

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021...(PR Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.